A-share Announcement Highlights | The first stock with a double increase this year, Jiangxi GETO New Materials Corporation (300986.SZ), issues a risk warning again.

Focus today 1. Jiangxi GETO New Materials Corporation, the first double-advance stock of the year: If the stock price continues to rise abnormally in the future, the company may apply for another trading halt for investigation. Jiangxi GETO New Materials Corporation announced that the company's stock price has risen by 211.27% from January 5, 2026, to January 21, 2026. The stock has experienced abnormal trading fluctuations multiple times during this period. Currently, the company's stock price has deviated significantly from its fundamentals, with a 'hot potato' effect, posing a risk of a significant short-term decline and high trading risks. The company suspended trading for investigation since January 13, 2026, and resumed trading after announcing the investigation results on January 16, 2026. If the company's stock price continues to rise abnormally in the future, the company may apply for another trading halt for investigation to the Shenzhen Stock Exchange. As of now, the company's business does not involve AI applications, artificial intelligence, quantum technology, Siasun Robot & Automation, or commercial aerospace, nor has it generated any related revenue. Since its listing, the company's main business has been the research and development, production, and sales of aluminum forms, protective platforms, prefabricated components, with no changes. The company and its subsidiaries are operating normally, with no significant undisclosed information. Note: According to statistics, Jiangxi GETO New Materials Corporation has accumulated a 211.3% increase in its stock price since the beginning of the year, becoming the first double-advance stock of the A-share market in the year. 2. Nanchang Mineral Systems: Signs a 296 million RMB equipment purchase agreement, accounting for 38.08% of the company's audited operating income in 2024 Nanchang Mineral Systems announced that it has recently signed a contract with Inner Mongolia Xijin Mining Co., Ltd. for the "Alashan Left Banner Xijin Mining 50 million tons/year crushing station project crushing and screening main equipment purchase contract," providing equipment to Xijin Mining at a total amount of 296 million RMB. This contract value accounts for 38.08% of the company's audited operating income in 2024 and is expected to have a positive impact on the company's operating income and profit for the current year and future years. 3. Optowide Technologies: Signs an 89.15 million RMB high-end optical component sales order in the field of optical communication to provide customized solutions for downstream OCS optical switch manufacturers Optowide Technologies announced that it has recently received a purchase order from a customer, Company C's subsidiary, with a total amount of 12.8 million US dollars (approximately 89.15 million RMB) for a two-dimensional collimator array product. This order is expected to have a positive impact on the company's operating performance. The specific amount and timing of the impact will depend on the specific circumstances of the order. The two-dimensional collimator array product supplied in this order is one of the company's key products in the high-end optical components field of optical communication. Leveraging the company's deep precision molding and assembly process capabilities, it can meet the custom requirements of downstream OCS optical switch manufacturers for collimator array products of different port quantities, providing critical component support for AI computing centers and ultra-large-scale optical interconnect network construction. 4. Jiangsu Hualan New Pharmaceutical Material: Plans to inject 450 million RMB into its wholly-owned subsidiary Lingqing Shuzhi to focus on AI innovative drug research and development solutions and services Jiangsu Hualan New Pharmaceutical Material announced that Hainan Lingqing Shuzhi Medical Technology Co., Ltd. (referred to as "Lingqing Shuzhi") is a wholly-owned subsidiary of the company and is an important business layout platform for the company in the AI pharmaceutical field. It mainly focuses on providing artificial intelligence innovative drug research and development solutions and services, helping advance the development and commercialization of artificial intelligence technology in drug research and application industries. Recognizing the fast-paced technological iterations, high research and development expenditures, and the requirements for strong capital and resource integration capabilities in the AI pharmaceutical industry, in order to further enhance the capital strength of its wholly-owned subsidiary, consolidate its future research and development and business expansion foundations, enhance its ability to connect with high-quality industrial resources, and promote deep cooperation with global upstream and downstream enterprises, technology teams, and research institutions, the company's board of directors agreed to inject 450 million RMB from its own funds into its wholly-owned subsidiary Lingqing Shuzhi. After this capital injection, Lingqing Shuzhi will remain a wholly-owned subsidiary of the company, and its registered capital will increase from 50 million RMB to 500 million RMB. 5. Beijing Hanjian Heshan Pipeline: Planning to acquire 52.51% equity of Liaoning Xingfu New Materials Co., Ltd. through stock issuance and cash payment, stock trading halted Beijing Hanjian Heshan Pipeline announced that the company is planning to acquire 52.51% equity of Liaoning Xingfu New Materials Co., Ltd. through issuing shares and paying cash in order to gain control of the target company and consolidate financial statements, as well as raise matching funds. This transaction does not constitute a related party transaction but constitutes a significant asset restructuring. In accordance with relevant regulations, the company's A-share stock has been suspended from January 22, 2026, with an expected suspension period not exceeding 9 trading days. Performance Forecast/Quick Report 1. Goldenmax International: Estimated net profit for 2025 is between 280 million RMB to 360 million RMB, a year-on-year increase of 655.53%-871.40%. 2. Dajin Heavy Industry: Estimated net profit for 2025 is between 1.05 billion RMB to 1.2 billion RMB, a year-on-year increase of 121.58%-153.23%. 3. Shenzhen Techwinsemi Technology: Estimated net profit for 2025 is between 650 million RMB to 800 million RMB, a year-on-year increase of 85.42%-128.21%. 4. Zhejiang Juhua: Estimated net profit for 2025 is between 3.54 billion RMB to 3.94 billion RMB, a year-on-year increase of 80% to 101%. 5. Cinda Real Estate: Estimated net loss for 2025 is between 7.6 billion RMB to 8.2 billion RMB. 6. Suzhou TFC Optical Communication: Estimated net profit for 2025 is between 1.881 billion RMB to 2.15 billion RMB, a year-on-year increase of 40%-60%. Stock Movement Risk Alerts 1. Guangdong Redwall New Materials, 2 consecutive trading boards: Expected annual performance for 2025 to turn from profit to loss. 2. Baiyin Nonferrous Group, 2 consecutive trading boards: Did not win the detailed exploration rights of the Qianhongquan Gold Mine in Yumen City, Gansu Province. 3. Hongbaoli Group Corporation, Ltd., 2 consecutive trading boards: The comprehensive technology transformation project of epoxy propane has entered the pre-production preparation stage. Review & Shareholding Changes 1. Hangzhou Alltest Biotech: Plans to repurchase company shares worth between 100 million RMB to 200 million RMB. 2. Yongan Futures: Shareholder Zhejiang Orient Financial Holdings Group plans to reduce its stake by no more than 3%. 3. Hangzhou Greenda Electronic Materials: Shareholder Juhe Investment plans to reduce its stake by no more than 3%. 4. Hefei Snowky Electric: Shareholder Zhidao Investment plans to reduce its stake by no more than 3%. 5. Colorlight Cloud Tech: Controlling shareholder and one of the ultimate controllers plan to reduce their stake by no more than 3%. 6. Zhejiang Huada New Materials: Shareholders collectively plan to reduce their stake by no more than 1.46%. Major Contracts Moon Environment Technology: Signed construction project contract, contract amount over 320 million RMB Other Sdic Zhonglu Fruit Juice: Company's asset restructuring and supporting financing plan approved by the State-owned Assets Supervision and Administration Commission of the State Council This article is republished from "Tencent Self-selected Stocks", GMTEight Editor: Chen Xiaoyi.